(Q45862024)

17 December 2017

title

Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus (English)

1 reference

17 December 2017

1 reference

6

1 reference

17 December 2017

Cornelis J. M. Melief

7

object named as

Cornelis J M Melief

1 reference

17 December 2017

Bianca Heemskerk

2

object named as

Bianca Heemskerk

1 reference

17 December 2017

Kees L M C Franken

8

object named as

Kees L M C Franken

1 reference

17 December 2017

author name string

Louise A Veltrop-Duits

1

1 reference

17 December 2017

Claudia C Sombroek

3

1 reference

17 December 2017

Tamara van Vreeswijk

4

1 reference

17 December 2017

Sophie Gubbels

5

1 reference

17 December 2017

Menzo Havenga

9

1 reference

17 December 2017

Maarten J D van Tol

10

1 reference

17 December 2017

Marco W Schilham

11

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

17 December 2017

European Journal of Immunology

published in

1 reference

17 December 2017

volume

36

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

2410-2423

1 reference

17 December 2017

Adenoviruses in the immunocompromised host

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

Increasing incidence of adenovirus disease in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenovirus infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenovirus infection after pediatric bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenovirus as an emerging pathogen in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Characterization of human proliferative T cell responses to adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Immune evasion by adenoviruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Hydropathic characteristics of adenovirus hexons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535786

7 January 2021

Identifiers

DOI

10.1002/EJI.200535786

1 reference

17 December 2017

1 reference

17 December 2017